Individual Variation in DNA Repair in Human Peripheral Blood Monocytes
The growing list of genetic and biological markers presently applied for predicting risk of human beings to manifest irreversible chemically induced disease is now legion. It includes at the cellular level such diverse endpoints as cytogenetics , mutagen/carcinogen metabolism, DNA damage and repair [2, 3], mutability, transformability , promotability, radiosensitivity, immunokinetics, and cell physiology. Yet, the list of suitable and accessible human tissues available is small, limited in practice to heterogeneous cultured skin cells of fibroblastic or epithelial morphology, peripheral blood lymphocytes , bone marrow, and organ autopsy or biopsy specimens. Each cell system has a common limitation in that baseline parameters which may not be stable or intrinsic are measured after some intervening culture manipulation. To circumvent this limitation, the studies to be discussed in this presentation have focused on the peripheral blood monocyte as a potential fresh ex vivo cell type in which to study selected endpoints [6, 7, 8]. Specifically, the extent of benzo[a]pyrene metabolism and unscheduled DNA synthesis after several DNA damaging treatments have been examined. These studies have lead to the realization that in vitro individuality in response to genetic damage is a complex function of both extra-genetic response to the agent(s) inflicting damage and possible genetically based peculiarities in processing of resultant lesions.
KeywordsBlood Monocyte Peripheral Blood Monocyte Genetic Damage Human Peripheral Blood Monocyte Amino Fluorene
Unable to display preview. Download preview PDF.
- 2.R. T. Barfknecht and J. B. Little, Abnormal sensitivity of skin fibroblasts from familial polyposis patients to DNA alkylating agents, Cancer Res., 42: 1249–1254 (1982).Google Scholar
- 3.N. G. J. Jaspers, J. de Wit, M. R. Regulski, and D. Bootsma, Abnormal regulation of DNA replication and increased lethality in Ataxia Telangiectasia cells exposed to carcinogenic agents, Cancer Res., 42: 335–341 (1982).Google Scholar
- 6.R. S. Lake, M. R. Pezzutti, M. L. Kropko, A. E. Freeman, and H. J. Igel, Measurement of benzo[a]pyrene metabolism in human monocytes, Cancer Res., 37: 2530–2537 (1977).Google Scholar
- 7.R. S. Lake, M. L. Kropko, S. McLachlan, M. R. Pezzutti, R. H. Shoemaker, and H. J. Igel, Chemical carcinogen induction of DNA-repair synthesis in human peripheral blood monocytes, Mut. Res., 74: 357–377 (1980).Google Scholar
- 8.M. W. Kahng, M. W. Smith, and B. F. Trump, Aryl hydrocarbon hydroxylase in human bronchial epithelium and blood monocyte, J. Natl. Cancer Inst., 66: 227–232 (1981).Google Scholar
- 10.A. Volkman, in: Immunobiology of the Macrophage ( D. S. Nelson, ed.), pp. 291–322, Academic Press, New York (1976).Google Scholar
- 12.G. M. Williams, Detection of chemical carcinogens by unscheduled DNA synthesis in rat liver primary cell cultures, Cancer Res., 37: 1845–1851 (1977).Google Scholar
- 13.C. J. Skidmore, M. I. Davies, P. M. Goodwin, 0. Omidiji, A. Zia’ee, and S. Shall, in: Novel ADP–Ribosylations of Regulatory Enzymes and Proteins (Smulson and Sugimura, eds.), pp. 197–205, Elsevier North Holland, Inc., Amsterdam (1980).Google Scholar
- 14.K. W. Kohn and R. A. Grimek-Ewig, Alkaline elution analysis, a new approach to the study of DNA single-strand interruptions in cells, Cancer Res., 33: 1849–1853 (1973).Google Scholar
- 15.H. C. Birnboim and J. J. Jevcak, Fluorometric method for rapid detection of DNA strand breaks in human blood cells produced by low doses of radiation, Cancer Res., 41:1889–1892 (1981).Google Scholar
- 16.E. S. Vesell, Intraspecies differences in frequency of genes directly affecting drug disposition: the individual factor in drug response, Pharm. Revs., 30:555–563 (1978).Google Scholar